title: Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
authors.forename: Lucie
authors.initials: L
authors.lastname: Blais
authors.forename: Fatima-Zohra
authors.initials: FZ
authors.lastname: Kettani
authors.forename: Sylvie
authors.initials: S
authors.lastname: Perreault
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Leroux
authors.forename: Amélie
authors.initials: A
authors.lastname: Forget
authors.forename: Marie-Jeanne
authors.initials: MJ
authors.lastname: Kergoat
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D005260:Female; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D048448:Phenylcarbamates / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D000068836:Rivastigmine
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D005702:Galantamine; D000077265:Donepezil; D000068836:Rivastigmine